Skip to content

Mounjaro 5 mg: the first step up

By the glp1doses editorial team
Every number is checked against FDA labels and official price pages. How we check

The short answer

Mounjaro 5 mg is the second step on the label, available after at least 4 weeks on 2.5 mg. Further increases are made only if more blood sugar control is needed, so 5 mg can be a long-term dose. A fill is four pens for 28 days. LillyDirect self-pay starts at $499 a month, the same as every other strength.

Source: LillyDirect self-pay

Key takeaways

  • Mounjaro 5 mg is available after at least 4 weeks on 2.5 mg.
  • You go higher only if more blood sugar control is needed. Otherwise the label doesn't call for an increase.
  • The label doesn't name maintenance doses, so your prescriber decides whether 5 mg is where you stay.
  • LillyDirect self-pay starts at $499 a month, so stepping up from 2.5 mg shouldn't change a self-pay bill.
  • If your commercial insurance covers Mounjaro, the savings card can lower a fill to as little as $25.

What the label says about Mounjaro 5 mg

Once weeklyA labelled maintenance doseAt least 28 days before any increase

Escalate only if additional glycemic control is needed; the label does not name specific maintenance doses.

If additional glycemic control is needed, increase the dosage in 2.5 mg increments after at least 4 weeks on the current dose.

Comes as: KwikPen (multi-dose, 4 weekly doses); Multi-dose vial (4 weekly doses); Single-dose pen; Single-dose vial.

FDA label: Revised: 8/2026 (DailyMed version 40)

Mounjaro dose schedule from the label

Put it on a calendar with the titration schedule builder. Only your prescriber decides when, and whether, your dose changes.

Supply per fill

Pack sizes from the "How supplied" section of the Mounjaro label
FormDoses per deviceDoses per fillDays per fillFills per year
KwikPen (multi-dose, 4 weekly doses)442813
Multi-dose vial (4 weekly doses)442813
Single-dose pen142813
Single-dose vial11752

Track run-out and refill dates with the supply tracker.

Mounjaro 5 mg: every way to pay, cheapest first

This table uses the 5 mg dose. Prices can differ at other doses, so use the cost calculator for yours. Swipe the table sideways to see conditions and sources.

Cost per fill, including any telehealth membership
How you payFormPer fillCost per mgConditionsSource
Manufacturer savings card (commercial insurance, drug covered)Single-dose pen$25$1.25
Conditions

Commercial drug insurance that covers Mounjaro. Pay as little as $25 for a 1-, 2- or 3-month fill; maximum savings $150 per 1-month, $300 per 2-month or $450 per 3-month fill, and $1,950 per calendar year; up to 13 fills per year. Month is 28 days and up to 4 pens. Government beneficiaries excluded. Card expires 12/31/2026.

mounjaro.lilly.com
LillyDirect self-paySingle-dose pen$499$24.95
Conditions

Self-pay only through LillyDirect; the same $499/month starting price is shown for every strength (2.5, 5, 7.5, 10, 12.5 and 15 mg). Prescription required; additional taxes and fees may apply; purchase terms apply.

lilly.com
Manufacturer savings card (commercial insurance, drug not covered)Single-dose pen$499$24.95
Conditions

Commercial drug insurance that does not cover Mounjaro. Pay as low as $499 per 1-month fill (28 days, up to 4 pens); maximum savings $647 per month and $8,411 per calendar year; up to 13 fills per year. Government beneficiaries excluded. Card expires 12/31/2026.

mounjaro.lilly.com

Savings-card and Medicare prices apply only if you are eligible. "From" prices that telehealth providers advertise are shown only at the lowest strength.

If you miss a dose of Mounjaro

  • You can move your weekly day, as long as there are at least 3 days between doses.

    The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours).
  • If it has been more than 4 days, skip it and take your next dose on your usual day.

    If more than 4 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once weekly dosing schedule.
  • If it has been 4 days or less, take it now and carry on with your usual weekly day.

    If a dose is missed, instruct patients to administer MOUNJARO as soon as possible within 4 days (96 hours) after the missed dose.

Enter your own dates in the missed-dose helper. If you are unsure, call your prescriber or pharmacist; never take two doses to catch up.

Mounjaro 5 mg is the first dose after the 2.5 mg start, and the lowest of the three strengths (5 mg, 10 mg and 15 mg) that the label’s trial tables report on. For some people it’s a stop on the way up. For others it’s where the dose stays.

Position in the schedule

The label’s rule for every step is the same sentence: “If additional glycemic control is needed, increase the dosage in 2.5 mg increments after at least 4 weeks on the current dose.” Glycemic control means blood sugar control. Here’s how that applies to 5 mg:

  • You can reach 5 mg after at least 4 weeks on 2.5 mg.
  • You can leave it for 7.5 mg after at least 4 more weeks, and only if more blood sugar control is needed.

Our dose record for Mounjaro notes that the label doesn’t name specific maintenance doses (doses you stay on). In practice, nothing on the label requires you to go further than 5 mg. The titration schedule tool shows the earliest dates for each possible step.

What the label reports at 5 mg

Two of the label’s 40-week trials in adults with type 2 diabetes tested 5 mg. HbA1c is a blood test that measures average blood sugar.

  • Monotherapy trial (Mounjaro on its own). Average HbA1c change was -1.8 on 5 mg and -0.1 on placebo (an inactive treatment). Average body-weight change was -6.3 kg on 5 mg and -1.0 kg on placebo.
  • Added to metformin, against semaglutide 1 mg. Average HbA1c change was -2.0 on Mounjaro 5 mg and -1.9 on semaglutide 1 mg.

On side effects, the label’s placebo-controlled pool reports nausea in 12% of people on 5 mg (4% on placebo), diarrhea in 12% (9% on placebo) and decreased appetite in 5% (1% on placebo). Gastrointestinal (stomach and gut) reactions led 3.0% of people on 5 mg to stop treatment, against 0.4% on placebo. These are group averages from trials, and your own experience may differ.

Price: no step at this step

On Lilly’s weight-management medicine, the price climbs with the early doses. Mounjaro’s doesn’t. LillyDirect self-pay starts at $499 a month for 5 mg, the figure shown for 2.5 mg and for every strength above. If you stay at 5 mg for a year, that’s $6,487 across 13 fills.

Most people with type 2 diabetes will use insurance instead. With commercial coverage, the savings card can lower a fill to as little as $25, subject to caps set out on the Mounjaro cost page.

Supply and forms

One fill is a carton of four single-dose 5 mg pens, a 28-day supply. The label also lists 5 mg as a single-dose vial, a multi-dose vial and a KwikPen holding four weekly doses. Every Mounjaro price on this page is for the single-dose pen. For the forms in detail, see the Mounjaro guide. For schedules across medicines, see the dosing hub.

Where to get Mounjaro

Some links on this page are affiliate links: if you sign up through them we may earn a commission at no extra cost to you. The cheapest legitimate option is always listed first, and payouts never affect rankings. How we make money.

  1. 1. Manufacturer savings card (commercial insurance, drug covered)

    $25 per fill at 5 mg

    Single-dose pen

    Source: mounjaro.lilly.comGo to the program page

  2. 2. LillyDirect self-pay

    $499 per fill at 5 mg

    Single-dose pen

    Source: lilly.comGo to the program page

  3. 3. Manufacturer savings card (commercial insurance, drug not covered)

    $499 per fill at 5 mg

    Single-dose pen

    Source: mounjaro.lilly.comGo to the program page

Ranked by cost only. Manufacturer and government programs never pay us. To see every option for your situation, try the cheapest-path quiz.

Frequently asked questions

Can you stay on Mounjaro 5 mg?

The label permits it. It says to raise the dose in 2.5 mg increments only if additional glycemic control (blood sugar control) is needed, and it doesn't name specific maintenance doses. If your blood sugar targets are met at 5 mg, the label doesn't call for a further increase. That judgment belongs to your prescriber, based on your results.

What did the trials show for Mounjaro 5 mg?

In the label's 40-week monotherapy trial (Mounjaro on its own), average HbA1c change on 5 mg was -1.8, against -0.1 on placebo, and average body-weight change was -6.3 kg, against -1.0 kg. In the 40-week trial added to metformin, HbA1c change was -2.0 on 5 mg and -1.9 on semaglutide 1 mg.

Does Mounjaro 5 mg cost more than 2.5 mg?

Not in the published prices. LillyDirect shows the same starting self-pay price, $499 a month, for all six strengths, and the list price of $1,112.16 is quoted per fill with no difference by strength. Stepping up from 2.5 mg to 5 mg shouldn't change a self-pay bill.

How common is nausea on Mounjaro 5 mg?

In the label's pool of placebo-controlled trials in adults with type 2 diabetes, nausea was reported by 12% of people taking 5 mg and 4% taking placebo. Diarrhea was reported by 12% on 5 mg and 9% on placebo. The label also reports that 3.0% of people on 5 mg stopped treatment because of gastrointestinal (stomach and gut) reactions.

Sources (7)

  1. 1.
    FDA label (DailyMed): Mounjaro prescribing information, section 14.2, Table 4
    “Table 4: Results at Week 40 in a Trial of MOUNJARO as Monotherapy in Adult Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control with Diet and Exercise. HbA1c (%) - Change at Week 40: Placebo: -0.1; MOUNJARO 5 mg: -1.8; MOUNJARO 10 mg: -1.7; MOUNJARO 15 mg: -1.7”
  2. 2.
    FDA label (DailyMed): Mounjaro prescribing information, section 14.2, Table 4
    “Table 4: Results at Week 40 in a Trial of MOUNJARO as Monotherapy in Adult Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control with Diet and Exercise. Body Weight (kg) - Change at Week 40: Placebo: -1.0; MOUNJARO 5 mg: -6.3; MOUNJARO 10 mg: -7.0; MOUNJARO 15 mg: -7.8”
  3. 3.
    FDA label (DailyMed): Mounjaro prescribing information, section 14.3, Table 5
    “Table 5: Results at Week 40 in a Trial of MOUNJARO versus Semaglutide 1 mg in Adult Patients with Type 2 Diabetes Mellitus Added to Metformin. HbA1c (%) - Change at Week 40: Semaglutide 1 mg: -1.9; MOUNJARO 5 mg: -2.0; MOUNJARO 10 mg: -2.2; MOUNJARO 15 mg: -2.3”
  4. 4.
  5. 5.
  6. 6.
  7. 7.